Life Sciences

Home > Practices > Technology and Intellectual Property > Life Sciences

Life Sciences

We act for clients in a wide variety of life science transactions, ranging from strategic licensing transactions and development and supply agreements, to biologic material transfers and technology transfers from research institutions, research agreements with large teaching hospitals, and contract research organization agreements. Our clients include medical device and biotechnology start-ups, international “big pharma” companies and technology transfer arms of research institutions. Our firm also advises on regulatory matters relating to the healthcare field.

Representative experience

License, purchase and sponsored research agreements between biotech start-ups and major multinational pharmaceutical companies, as well as agreements between biotech start-ups and the technology transfer arms of research institutes, such as the University of Texas (MD Anderson), MIT, Stanford, the Weizmann Institute (Yeda), Hebrew University (Yissum), Sheba, Technion, Tel Aviv University (Ramot), Hadassah (Hadasit) and Brigham & Women’s Hospital.
Clinical trial agreements between biotech start-ups and medical centers around the world, including privately-owned and governmental institutes, and related agreements such as agreements with multinational CROs.
Supply and distribution agreements between pharmaceutical companies and distributors such as Omrix Biopharmaceuticals and local distributors in Europe, the Middle East and the Far East.
Manufacturing agreements for drugs or medical products, with special attention to the unique requirements of the pharmaceutical fields.
Sourcing agreements between local biotech companies and multi-national companies for supply and delivery of biological materials, related materials and services with respect to trials, clinical trials and manufacturing.
Co-operation, collaborations and co-marketing agreements between local biotech companies or between local biotech companies and foreign pharmaceutical companies.
Special collaborations between local and foreign biotech companies under various international programs.